These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 33206936)

  • 1. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
    Klintman J; Appleby N; Stamatopoulos B; Ridout K; Eyre TA; Robbe P; Pascua LL; Knight SJL; Dreau H; Cabes M; Popitsch N; Ehinger M; Martín-Subero JI; Campo E; Månsson R; Rossi D; Taylor JC; Vavoulis DV; Schuh A
    Blood; 2021 May; 137(20):2800-2816. PubMed ID: 33206936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.
    Appleby N; Eyre TA; Cabes M; Jackson A; Boucher R; Yates F; Fox S; Rawstron A; Hillmen P; Schuh A
    BMC Cancer; 2019 May; 19(1):471. PubMed ID: 31109313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
    Kanagal-Shamanna R; Jain P; Patel KP; Routbort M; Bueso-Ramos C; Alhalouli T; Khoury JD; Luthra R; Ferrajoli A; Keating M; Jain N; Burger J; Estrov Z; Wierda W; Kantarjian HM; Medeiros LJ
    Cancer; 2019 Feb; 125(4):559-574. PubMed ID: 30508305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.
    Eyre TA; Clifford R; Roberts C; Boyle L; Francis A; Schuh A; Dutton SJ
    BMC Cancer; 2015 Feb; 15():52. PubMed ID: 25775024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
    Fabbri G; Khiabanian H; Holmes AB; Wang J; Messina M; Mullighan CG; Pasqualucci L; Rabadan R; Dalla-Favera R
    J Exp Med; 2013 Oct; 210(11):2273-88. PubMed ID: 24127483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome.
    Matolcsy A; Casali P; Knowles DM
    Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update for Richter syndrome - new directions and developments.
    Eyre TA; Schuh A
    Br J Haematol; 2017 Aug; 178(4):508-520. PubMed ID: 28439883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
    Davies A; Cummin TE; Barrans S; Maishman T; Mamot C; Novak U; Caddy J; Stanton L; Kazmi-Stokes S; McMillan A; Fields P; Pocock C; Collins GP; Stephens R; Cucco F; Clipson A; Sha C; Tooze R; Care MA; Griffiths G; Du MQ; Westhead DR; Burton C; Johnson PWM
    Lancet Oncol; 2019 May; 20(5):649-662. PubMed ID: 30948276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
    Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
    Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richter syndrome in B-cell chronic lymphocytic leukemia.
    Nakamura N; Abe M
    Pathol Int; 2003 Apr; 53(4):195-203. PubMed ID: 12675762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
    Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
    Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.
    Chigrinova E; Rinaldi A; Kwee I; Rossi D; Rancoita PM; Strefford JC; Oscier D; Stamatopoulos K; Papadaki T; Berger F; Young KH; Murray F; Rosenquist R; Greiner TC; Chan WC; Orlandi EM; Lucioni M; Marasca R; Inghirami G; Ladetto M; Forconi F; Cogliatti S; Votavova H; Swerdlow SH; Stilgenbauer S; Piris MA; Matolcsy A; Spagnolo D; Nikitin E; Zamò A; Gattei V; Bhagat G; Ott G; Zucca E; Gaidano G; Bertoni F
    Blood; 2013 Oct; 122(15):2673-82. PubMed ID: 24004666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Richter syndrome: an aggressive transformation.
    Streu E
    Oncol Nurs Forum; 2015 Mar; 42(2):200-3. PubMed ID: 25806888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
    Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
    Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
    Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
    Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
    Broséus J; Hergalant S; Vogt J; Tausch E; Kreuz M; Mottok A; Schneider C; Dartigeas C; Roos-Weil D; Quinquenel A; Moulin C; Ott G; Blanchet O; Tomowiak C; Lazarian G; Rouyer P; Chteinberg E; Bernhart SH; Tournilhac O; Gauchotte G; Lomazzi S; Chapiro E; Nguyen-Khac F; Chery C; Davi F; Hunault M; Houlgatte R; Rosenwald A; Delmer A; Meyre D; Béné MC; Thieblemont C; Lichter P; Ammerpohl O; Guéant JL; ; Guièze R; Martin-Subero JI; Cymbalista F; Feugier P; Siebert R; Stilgenbauer S
    Nat Commun; 2023 Jan; 14(1):309. PubMed ID: 36658118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
    Davids MS; Rogers KA; Tyekucheva S; Wang Z; Pazienza S; Renner SK; Montegaard J; Ihuoma U; Lehmberg TZ; Parry EM; Wu CJ; Jacobson CA; Fisher DC; Thompson PA; Brown JR
    Blood; 2022 Feb; 139(5):686-689. PubMed ID: 34788401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
    Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
    Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.